As pharmaceutical stakeholders continue to work through the U.S. Food and Drug Administration (FDA)-granted exemption period, industry leaders from the wholesaler and dispenser community highlight efforts underway to solve remaining challenges using GS1 Standards and steps that can be taken to meet final requirements of the Drug Supply Chain Security Act (DSCSA). By highlighting accomplishments, emphasizing resolutions to 340B and exception challenges, and outlining action you can take now, this session offers practical guidance as key takeaways for attendees.